4.7 Article

Subtyping depression in the medically ill by cluster analysis

Journal

JOURNAL OF AFFECTIVE DISORDERS
Volume 132, Issue 3, Pages 383-388

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jad.2011.03.004

Keywords

Major depressive disorder; Diagnostic Criteria for Psychosomatic; Research; Medically ill; Cluster analysis

Funding

  1. Compagnia di San Paolo, Torino, Italy
  2. Ely-Lilly
  3. Janssen-Cilag
  4. AstraZeneca
  5. Bristol Meyers Squibb
  6. Lundbeck
  7. Pfeizer
  8. Glaxo-SmithKline

Ask authors/readers for more resources

Background: There is increasing awareness of the need of subtyping major depressive disorder, particularly in the setting of medical disease. The aim of this investigation was to use both DSM-IV comorbidity and the Diagnostic Criteria for Psychosomatic Research (DCPR) for characterizing depression in the medically ill. Methods: 1700 patients were recruited from 8 medical centers in the Italian Health System and 1560 agreed to participate. They all underwent a cross-sectional assessment with DSM-IV and DCPR structured interviews. 198 patients (12.7%) received a diagnosis of major depressive disorder. Data were submitted to cluster analysis. Results: Two clusters were identified: depressed somatizers and irritable/anxious depression. The somatizer cluster included 58.6% of the cases and was characterized by DCPR somatization syndromes (persistent somatization, functional somatic symptoms secondary to a psychiatric disorder, conversion symptoms, and anniversary reactions) and DCPR alexithymia. The anxious/irritable cluster had 41.4% of the total sample and included DCPR irritable mood and type A behavior and DSM-IV anxiety disorders. Limitations: The study has limitations due to its cross-sectional nature. Further, these findings require additional validation in another sample. Conclusions: The findings indicate the need of expanding clinical assessment in the medically ill to include the various manifestations of somatization, irritable mood, type A behavior and alexithymia, as encompassed by the DCPR. Subtyping major depressive disorder may yield improved targets for psychosomatic research and treatment trials. (C) 2011 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available